MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to rani...
-$7,033,000
(3.18%↑ Y/Y)
Net gain
attributable to...
-$982,000
(82.06%↑ Y/Y)
Net loss
-$8,015,000
(37.08%↑ Y/Y)
Interest income and
other, net
$412,000
(88.99%↑ Y/Y)
Loss from operations
-$8,339,000
(30.58%↑ Y/Y)
Contract revenue
$1,708,000
(893.02%↑ Y/Y)
Interest expense and
other, net
$88,000
(-90.67%↓ Y/Y)
Total operating
expenses
$10,047,000
(-17.55%↓ Y/Y)
Research and development
$5,161,000
(-21.45%↓ Y/Y)
General and
administrative
$4,886,000
(-12.98%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)